Telix names Marcin Firek company secretary
TLX•Telix Pharmaceuticals appointed Marcin Firek as company secretary effective October 21, 2026, and David Gill as board chair effective September 1, 2026. Firek most recently led enterprise and operational risk at PwC Australia; Shomalin Naidoo ceased serving as interim company secretary on October 20.
1. Leadership appointments
Telix Pharmaceuticals appointed David Gill board chair effective September 1, 2026. Marcin Firek will join as company secretary effective October 21, replacing interim company secretary Shomalin Naidoo, who ceased serving on October 20. Firek most recently served as head of enterprise and operational risk at PwC Australia, following senior company secretary roles; Gill has over 35 years of life sciences experience.
